Crinetics Pharmaceuticals... (CRNX)
NASDAQ: CRNX
· Real-Time Price · USD
29.45
-0.29 (-0.98%)
At close: Aug 19, 2025, 3:59 PM
30.24
2.68%
After-hours: Aug 19, 2025, 07:42 PM EDT
Crinetics Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.03M | 361K | n/a | n/a | 399K | 640K | n/a | 346K | 988K | 2.68M | 709K | 458K | 439K | 3.13M | 1.08M | n/a | n/a | n/a |
Cost of Revenue | 959K | n/a | 1.23M | 770K | 753K | 474K | 262K | 273K | 398K | 398K | 388K | 351K | 315K | 335K | 1.08M | 319K | 313K | 304K |
Gross Profit | 72K | 361K | 188K | -770K | -57.95M | -474K | -262K | 73K | 590K | 2.28M | 321K | 107K | 124K | 2.8M | 1.08K | -319K | -313K | -304K |
Operating Income | -129.11M | -111.41M | -94.75M | -87.8M | -82.78M | -73.53M | -62.66M | -58.98M | -52.99M | -47.98M | -47.56M | -43.45M | -43.05M | -33.83M | -30.89M | -27.81M | -26.09M | -22.92M |
Interest Income | 13.46M | 14.83M | 14.37M | 11.01M | 8.74M | 7.32M | 6.72M | 2.57M | 2.11M | 2.04M | 1.9M | 1.5M | 720K | 193K | 80K | 24K | 23K | 30K |
Pretax Income | -115.64M | -96.77M | -80.59M | -76.83M | -74.06M | -66.93M | -60.1M | -57.46M | -50.98M | -45.99M | -44.99M | -41.92M | -42.38M | -34.63M | -30.79M | -27.85M | -26.09M | -22.9M |
Net Income | -115.64M | -96.77M | -80.59M | -76.83M | -74.06M | -66.93M | -60.1M | -57.46M | -50.98M | -44.01M | -42.43M | -40.4M | -41.7M | -35.43M | -30.79M | -27.85M | -26.09M | -22.9M |
Selling & General & Admin | 49.84M | 35.53M | 28.18M | 25.89M | 24.84M | 20.83M | 17.08M | 15.48M | 13.34M | 12.19M | 11.27M | 11.93M | 10.49M | 8.71M | 7.36M | 6.23M | 5.6M | 5.33M |
Research & Development | 80.3M | 76.24M | 66.57M | 61.91M | 58.34M | 52.87M | 45.32M | 43.84M | 40.64M | 38.47M | 36.99M | 31.99M | 32.99M | 28.25M | 24.6M | 21.58M | 20.49M | 17.58M |
Other Expenses | n/a | n/a | -788K | n/a | -58.34M | n/a | n/a | n/a | -91K | n/a | n/a | 29K | -81K | 17K | 94K | -68K | -29K | -13K |
Operating Expenses | 130.14M | 111.77M | 93.96M | 87.8M | 24.84M | 73.69M | 62.4M | 59.32M | 53.98M | 50.66M | 48.27M | 43.91M | 43.48M | 36.96M | 31.97M | 27.81M | 26.09M | 22.92M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 130.14M | 111.77M | 94.75M | 87.8M | 83.18M | 74.17M | 62.66M | 59.32M | 53.98M | 50.66M | 48.27M | 43.91M | 43.48M | 36.96M | 31.97M | 27.81M | 26.09M | 22.92M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -273K | n/a | -1.98M | -2.56M | -1.53M | -670K | 800K | n/a | -24K | -23K | -30K |
Shares Outstanding (Basic) | 93.79M | 93.1M | 91.49M | 80.09M | 79.01M | 72.29M | 67.15M | 56.81M | 54.27M | 53.91M | 53.84M | 53.77M | 52.52M | 47.43M | 45.23M | 38.31M | 37.06M | 33.01M |
Shares Outstanding (Diluted) | 93.79M | 93.1M | 91.49M | 80.09M | 79.01M | 72.29M | 67.15M | 56.81M | 54.27M | 53.91M | 53.84M | 53.77M | 52.52M | 47.71M | 45.23M | 38.31M | 37.06M | 33.01M |
EPS (Basic) | -1.23 | -1.04 | -0.88 | -0.96 | -0.94 | -0.93 | -0.89 | -1.01 | -0.94 | -0.82 | -0.79 | -0.75 | -0.79 | -0.75 | -0.68 | -0.73 | -0.7 | -0.69 |
EPS (Diluted) | -1.23 | -1.04 | -0.88 | -0.96 | -0.94 | -0.93 | -0.89 | -1.01 | -0.94 | -0.82 | -0.79 | -0.75 | -0.79 | -0.74 | -0.68 | -0.73 | -0.7 | -0.69 |
EBITDA | -129.11M | -110.48M | -93.96M | -87.03M | -82.03M | -73.06M | -62.4M | -58.7M | -52.72M | -47.7M | -47.28M | -43.21M | -42.83M | -33.59M | -30.65M | -27.57M | -25.86M | -22.69M |
EBIT | -115.64M | -111.41M | -94.75M | -87.8M | -82.78M | -73.53M | -62.66M | -58.98M | -52.99M | -47.98M | -47.56M | -43.45M | -43.05M | -33.83M | -30.89M | -27.81M | -26.09M | -22.92M |
Depreciation & Amortization | 959K | 925K | 788K | 770K | 753K | 474K | 262K | 273K | 398K | 398K | 388K | 351K | 315K | 335K | 326K | 319K | 313K | 304K |